Junctional Adhesion Molecule B

A junctional adhesion molecule subtype that is localized to high endothelial VENULES, heart ENDOTHELIUM, TROPHOBLASTS of the PLANCENTA, and in the ENDOTHELIUM of ARTERIOLES.

Also Known As:

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Fu, Yong: 1 article (02/2022)
2.	Guo, Shipeng: 1 article (02/2022)
3.	Li, Han: 1 article (02/2022)
4.	Liu, Shengchun: 1 article (02/2022)
5.	Peng, Yang: 1 article (02/2022)
6.	Qu, Chi: 1 article (02/2022)
7.	Zhang, Yingzi: 1 article (02/2022)
8.	Zong, Beige: 1 article (02/2022)
9.	Barbe, Florence: 1 article (03/2021)
10.	Bilal, Muhammad: 1 article (03/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2020 - "Junctional adhesion molecule B (JAM-B) is a multifunctional transmembrane protein that plays an important role in tumor progression. "
2.	Neoplasm Metastasis (Metastasis) 11/16/2012 - "The Junctional Adhesion Molecule-B regulates JAM-C-dependent melanoma cell metastasis."
3.	Melanoma (Melanoma, Malignant) 11/16/2012 - "The Junctional Adhesion Molecule-B regulates JAM-C-dependent melanoma cell metastasis."
4.	Herpes Zoster 03/01/2021 - "Expression of tight junction protein increased significantly in the ileum on day 14 in the BPL (occludin, zona occludens 1 [ZO-1]), BSL (occludin, ZO-1), and BSH (occludin, ZO-1, junctional adhesion molecule 2 [JAM-2]) groups compared with that in the Con group and declined in all groups except in the BSH group (occludin, ZO-1, JAM-2) on day 42. "
5.	Breast Neoplasms (Breast Cancer) 02/01/2022 - "Junctional adhesion molecule 2 (JAM2), which is located on chromosome 21, is expressed at low levels in breast cancer and is associated with a good prognosis. "

Related Drugs and Biologics

1.	Occludin
2.	Tight Junction Proteins
3.	Proteins (Proteins, Gene)